EcoDrugPlus

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSBTAG00000000396
Gene Symbol: PIM1
5 Cross references
260 Possible Orthologues:

Pim-2 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSBTAG00000004597
Gene Symbol: PIM2
5 Cross references
127 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSBTAG00000045904
Gene Symbol: PIM3
5 Cross references
207 Possible Orthologues:

Rar Related Orphan Receptor C

Ensembl ID : ENSBTAG00000017405
Gene Symbol: RORC
4 Enzyme and pathways 5 Cross references
396 Possible Orthologues:

Rela Proto-Oncogene, Nf-Kb Subunit

Ensembl ID : ENSBTAG00000013895
Gene Symbol: RELA
55 Enzyme and pathways 5 Cross references
212 Possible Orthologues:

Ros Proto-Oncogene 1, Receptor Tyrosine Kinase

Ensembl ID : ENSBTAG00000047600
Gene Symbol: ROS1
5 Cross references
137 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSBTAG00000045748
Gene Symbol: RAF1
4 Cross references
236 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSBTAG00000008403
Gene Symbol: ROCK1
33 Enzyme and pathways 5 Cross references
223 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSBTAG00000005847
Gene Symbol: ROCK2
25 Enzyme and pathways 5 Cross references
310 Possible Orthologues:

Sem1 26s Proteasome Subunit

Ensembl ID : ENSBTAG00000052508
Gene Symbol: SEM1
4 Cross references
158 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSBTAG00000008938
Gene Symbol: SRC
99 Enzyme and pathways 5 Cross references
273 Possible Orthologues:

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSBTAG00000020148
Gene Symbol: TEK
7 Enzyme and pathways 5 Cross references
178 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).